Fast-growing growth hormone transgenic coho salmon (Oncorhynchus kisutch) show a lower incidence of vaterite deposition and malformations in sagittal otoliths

dc.contributor.authorChalan, Irvin
dc.contributor.authorSolsona, Laia
dc.contributor.authorColl-Lladó, Clara
dc.contributor.authorWebb, Paul Brian
dc.contributor.authorSakhrani, Dionne
dc.contributor.authorDevlin, Robert H.
dc.contributor.authorGarcía de la Serrana Castillo, Daniel
dc.date.accessioned2023-02-28T10:18:38Z
dc.date.available2023-02-28T10:18:38Z
dc.date.issued2022-10-01
dc.date.updated2023-02-28T10:18:38Z
dc.description.abstractIn fish otoliths, CaCO3 normally precipitates as aragonite, and more rarely as vaterite or calcite. A higher incidence of vaterite deposition in otoliths from aquaculture-reared fish has been reported and it is thought that high growth rates under farming conditions might promote its deposition. To test this hypothesis, otoliths from growth hormone (GH) transgenic coho salmon and non-transgenic fish of matching size were compared. Once morphometric parameters were normalized by animal length, we found that transgenic fish otoliths were smaller (−24%, −19%, −20% and −30% for length, width, perimeter and area, respectively; P<0.001) and rounder (−12%, +13.5%, +15% and −15.5% in circularity, form factor, roundness and ellipticity; P<0.001) than otoliths from non-transgenic fish of matching size. Interestingly, transgenic fish had smaller eyes (−30% eye diameter) and showed a strong correlation between eye and otolith size. We also found that the percentage of otoliths showing vaterite deposition was significantly smaller in transgenic fish (21-28%) than in non-transgenic fish (69%; P<0.001). Likewise, the area affected by vaterite deposition within individual otoliths was reduced in transgenic fish (21-26%) compared with non-transgenic fish (42.5%; P<0.001). Our results suggest that high growth rates per se are not sufficient to cause vaterite deposition in all cases, and that GH overexpression might have a protective role against vaterite deposition, a hypothesis that needs further investigation.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec730793
dc.identifier.issn0022-0949
dc.identifier.urihttps://hdl.handle.net/2445/194311
dc.language.isoeng
dc.publisherThe Company of Biologists
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1242/jeb.244099
dc.relation.ispartofJournal of Experimental Biology, 2022, vol. 22, num. 19
dc.relation.urihttps://doi.org/10.1242/jeb.244099
dc.rightscc by (c) Chalan, Irvin et al., 2022
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia)
dc.subject.classificationAnimals transgènics
dc.subject.classificationOtòlits
dc.subject.classificationSalmònids
dc.subject.otherTransgenic animals
dc.subject.otherOtoliths
dc.subject.otherSalmonidae
dc.titleFast-growing growth hormone transgenic coho salmon (Oncorhynchus kisutch) show a lower incidence of vaterite deposition and malformations in sagittal otoliths
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
730793.pdf
Mida:
2.2 MB
Format:
Adobe Portable Document Format